Three small caps with takeover upside
Three small caps with takeover upside
About this video
Key points:
Tyro Payments (ASX:TYR) seen benefiting from RBA payment reforms, enhanced takeover appeal
Apiam Animal Health (ASX:AHX) identified for turnaround and industry consolidation potential
A narrow group (ASX:ANO) highlighted after business exits, with core agency value and capital management prospects
Sector trends and regulatory changes viewed as key catalysts for growth and M&A activity
Ron Shamgar from TAMIM Asset Management outlines his current focus on three small-cap stocks, highlighting their potential in a changing regulatory and business landscape. Shamgar identifies Tyro Payments (ASX:TYR) as a prime beneficiary of the Reserve Bank of Australia’s proposed reduction in interchange fees, projecting an additional $100 million to the company’s gross profit based on $43 billion in transaction value. He points to Tyro’s strong competitive position, particularly as only a small portion of its merchant base is at risk due to surcharge changes. With strong EBITDA and net cash, Shamgar suggests Tyro could become an acquisition target, following recent sector deals involving Smartpay and rumoured interest from companies like Stripe or Shift4.
Turning to Apiam Animal Health (ASX:AHX), Shamgar highlights its position as Australia’s third largest vet clinic operator, now under the leadership of a new CEO and major shareholder. He expects margin improvements at the clinic level and significant cost savings at the group level, with market dynamics favouring increased demand for veterinary services as pets age. He sees the sector as ripe for consolidation and M&A, with Apiam potentially receiving takeover interest at valuations above a dollar.
Enero Group (ASX: ENO) also features, with Shamgar noting recent divestments simplifying its business structure. He sees value in its core agency businesses and expects potential for capital management initiatives in upcoming results.